Key Insights

Highlights

Success Rate

84% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 72/100

Termination Rate

13.6%

3 terminated out of 22 trials

Success Rate

84.2%

-2.3% vs benchmark

Late-Stage Pipeline

5%

1 trials in Phase 3/4

Results Transparency

6%

1 of 16 completed with results

Key Signals

1 with results84% success

Data Visualizations

Phase Distribution

9Total
Not Applicable (4)
P 1 (3)
P 2 (1)
P 3 (1)

Trial Status

Completed16
Terminated3
Recruiting2
Not Yet Recruiting1

Trial Success Rate

84.2%

Benchmark: 86.5%

Based on 16 completed trials

Clinical Trials (22)

Showing 20 of 20 trials
NCT04330118RecruitingPrimary

Origin and Function of Eosinophilic Polynuclear During DRESS Syndrome

NCT06406114Phase 2Recruiting

Optimizing the Diagnostic Approach to Cephalosporin Allergy Testing

NCT07390370Not Yet RecruitingPrimary

Establishment of a Registry for Immediate Drug Allergy

NCT07069439CompletedPrimary

Turkish Version of the Parent-Reported Drug Hypersensitivity Quality of Life Questionnaire

NCT02839551Not ApplicableCompletedPrimary

Optimal Doses for Drug Provocation Tests to Beta-lactams

NCT02031120TerminatedPrimary

Management of Drug Hypersensitivity in Children

NCT06428162Completed

An Evaluation of Healthcare Providers' Adherence to Pharmacovigilance Practices in an African Community

NCT06523192CompletedPrimary

Validation of the English Version of the Drug Hypersensitivity Quality of Life Questionnaire

NCT05269082CompletedPrimary

A Study to Assess the Hypersensitivity to TAK-880 Compared to Gammagard S/D in Blood of Children, Teenagers and Adults

NCT04827602CompletedPrimary

Drug Allergy Labels After Drug Allergy Investigation

NCT02839811Not ApplicableCompletedPrimary

Medical Device for Drug Allergy Diagnosis

NCT03158831Phase 1CompletedPrimary

Drug Challenges Without Prior Skin Testing

NCT04421638CompletedPrimary

Cephalosporin Hypersensitivity

NCT03771118CompletedPrimary

Drug Provocation Test (DPT) to Paracetamol

NCT03743220CompletedPrimary

Drug Provocation Test (DPT) to Non Steroidal Anti-inflammatory Drugs (NSAID)

NCT02983630CompletedPrimary

Allergy Testing of Patients Labeled as Penicillin Allergic

NCT01276314Not ApplicableCompletedPrimary

Evaluation of TNF-α Blockade Effect in Patients With Severe Cutaneous Adverse Drug Reactions

NCT03076749CompletedPrimary

Predictive Models for Betalactam Allergy

NCT02844712Not ApplicableTerminatedPrimary

Negative Predictive Value of Drug Provocation Tests to Beta-lactams

NCT00505648Phase 3TerminatedPrimary

Treatment of Hypersensitivity Syndrome (DRESS) With Tegeline® (Human Immunoglobulin)

Scroll to load more

Research Network

Activity Timeline